1α,25-Dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis

Journal of Autoimmunity

Volumn 23, Issue 3, 2004, Pages 233-239

  Van Halteren, Astrid G S ^a   Tysma, Odette M ^a   Van Etten, Evelyne ^b   Mathieu, Chantal ^b   Roep, Bart O ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Apoptosis; Dendritic cells; T lymphocytes; Type 1 diabetes

Indexed keywords

19 NOR 14,20 BISEPI 23 YNE 1,25 DIHYDROXYCHOLECALCIFEROL D 3; CALCITRIOL; CALCITRIOL DERIVATIVE; LIPOCORTIN 5; TX 527; UNCLASSIFIED DRUG; DIHYDROXY VITAMIN D3; DIHYDROXY-VITAMIN D3; DRUG DERIVATIVE; GAMMA INTERFERON; VITAMIN D;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; AUTOIMMUNITY; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; KINETICS; LYMPHOCYTE ACTIVATION; SECRETION; TIME;

APOPTOSIS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; INTERFERON TYPE II; KINETICS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TIME FACTORS; VITAMIN D;

EID: 14244263382     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2004.06.004     Document Type: Article

References (39)

1. B.O. Roep The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure Diabetologia 46 2003 305 321
2. Y. Mori, M. Suko, H. Okudaira, I. Matsuba, A. Tsuruoka, and A. Sasaki Preventive effects of cyclosporin on diabetes in NOD mice Diabetologia 29 1986 244 247
3. K.C. Herold, A.G. Montag, and F.W. Fitch Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin Diabetes 36 1987 796 801
4. L. Chatenoud, E. Thervet, J. Primo, and J.F. Bach Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice Proc Natl Acad Sci U S A 91 1994 123 127
5. A.M. Shapiro, W.L. Suarez-Pinzon, R. Power, and A. Rabinovitch Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice Diabetologia 45 2002 224 230
6. K.C. Herold, W. Hagopian, J.A. Auger, E. Poumian-Ruiz, L. Taylor, and D. Donaldson Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus N Engl J Med 346 2002 1692 1698
7. A.M. Shapiro, J.R. Lakey, E.A. Ryan, G.S. Korbutt, E. Toth, and G.L. Warnock Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 2000 230 238
8. I. Stobbe, G. Duinkerken, J.J. van Rood, A. Lernmark, B. Keymeulen, and D. Pipeleers Tolerance to kidney allograft transplanted into type I diabetic patients persists after in vivo challenge with pancreatic islet allografts that express repeated mismatches Diabetologia 42 1999 1379 1380
9. A.G. van Halteren, E. van Etten, E.C. de Jong, R. Bouillon, B.O. Roep, and C. Mathieu Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3) Diabetes 51 2002 2119 2125
10. G. Penna, and L. Adorini 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation J Immunol 164 2000 2405 2411
11. M.D. Griffin, W. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean, and R. Kumar Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo Proc Natl Acad Sci U S A 98 2001 6800 6805
12. J.M. Lemire Immunomodulatory actions of 1,25-dihydroxyvitamin D3 J Steroid Biochem Mol Biol 53 1995 599 602
13. L. Piemonti, P. Monti, P. Allavena, M. Sironi, L. Soldini, and B.E. Leone Glucocorticoids affect human dendritic cell differentiation and maturation J Immunol 162 1999 6473 6481
14. A.M. Woltman, and C. van Kooten Functional modulation of dendritic cells to suppress adaptive immune responses J Leukoc Biol 73 2003 428 441
15. P. Kalinski, C.M. Hilkens, E.A. Wierenga, and M.L. Kapsenberg T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal Immunol Today 20 1999 561 567
16. R. Manetti, P. Parronchi, M.G. Giudizi, M.P. Piccinni, E. Maggi, and G. Trinchieri Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells J Exp Med 177 1993 1199 1204
17. C.M. Hilkens, A. Snijders, H. Vermeulen, P.H. van der Meide, E.A. Wierenga, and M.L. Kapsenberg Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells J Immunol 156 1996 1722 1727
18. S. Trembleau, G. Penna, S. Gregori, M.K. Gately, and L. Adorini Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes Eur J Immunol 27 1997 2330 2339
19. L. Piemonti, P. Monti, M. Sironi, P. Fraticelli, B.E. Leone, and E. Dal Cin Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells J Immunol 164 2000 4443 4451
20. L. Overbergh, B. Decallonne, M. Waer, O. Rutgeerts, D. Valckx, and K.M. Casteels 1Alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543) Diabetes 49 2000 1301 1307
21. A. Boonstra, F.J. Barrat, C. Crain, V.L. Heath, H.F. Savelkoul, and A. O'Garra 1Alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells J Immunol 167 2001 4974 4980
22. L. Verlinden, A. Verstuyf, M. Van Camp, S. Marcelis, K. Sabbe, and X.Y. Zhao Two novel 14-epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo Cancer Res 60 2000 2673 2679
23. E. van Etten, D.D. Branisteanu, A. Verstuyf, M. Waer, R. Bouillon, and C. Mathieu Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants Transplantation 69 2000 1932 1942
24. N.C. Schloot, M.C. Batstra, G. Duinkerken, R.R. De Vries, T. Dyrberg, and A. Chaudhuri GAD65-reactive T cells in a non-diabetic stiff-man syndrome patient J Autoimmun 12 1999 289 296
25. E. Van Vliet, B.O. Roep, L. Meulenbroek, G.J. Bruining, and R.R. De Vries Human T cell clones with specificity for insulinoma cell antigens Eur J Immunol 19 1989 213 216
26. B.O. Roep, S.D. Arden, R.R. De Vries, and J.C. Hutton T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins Nature 345 1990 632 634
27. P.I. Neophytou, B.O. Roep, S.D. Arden, E.M. Muir, G. Duinkerken, and A. Kallan T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38-kDA autoantigen recognized by T cells from an insulin-dependent diabetic patient Proc Natl Acad Sci U S A 93 1996 2014 2018
28. G.B. Fazekas de St, A.L. Smith, W.P. Koh, L. Girgis, M.C. Cook, and P. Bertolino Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven Immunol Cell Biol 77 1999 530 538
29. T.H. Ottenhoff, and T. Mutis Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man J Exp Med 171 1990 2011 2024
30. D.H. Lynch, F. Ramsdell, and M.R. Alderson Fas and FasL in the homeostatic regulation of immune responses Immunol Today 16 1995 569 574
31. C. Petrovas, Y.M. Mueller, I.D. Dimitriou, P.M. Bojczuk, K.C. Mounzer, and J. Witek HIV-specific CD8(+) T cells exhibit markedly reduced levels of Bcl-2 and Bcl-x(L) J Immunol 172 2004 4444 4453
32. L. Adorini, N. Giarratana, and G. Penna Pharmacological induction of tolerogenic dendritic cells and regulatory T cells Semin Immunol 16 2004 127 134
33. J.V. Ravetch, and L.L. Lanier Immune inhibitory receptors Science 290 2000 84 89
34. C.C. Chang, R. Ciubotariu, J.S. Manavalan, J. Yuan, A.I. Colovai, and F. Piazza Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4 Nat Immunol 3 2002 237 243
35. S. Gregori, N. Giarratana, S. Smiroldo, M. Uskokovic, and L. Adorini A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice Diabetes 51 2002 1367 1374
36. C. Mathieu, J. Laureys, H. Sobis, M. Vandeputte, M. Waer, and R. Bouillon 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice Diabetes 41 1992 1491 1495
37. C. Mathieu, M. Waer, J. Laureys, O. Rutgeerts, and R. Bouillon Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 Diabetologia 37 1994 552 558
38. C.G. Figdor, I.J. De Vries, W.J. Lesterhuis, and C.J. Melief Dendritic cell immunotherapy: mapping the way Nat Med 10 2004 475 480
39. M. Gilliet, and Y.J. Liu Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells J Exp Med 195 2002 695 704